Anti-PIGH monoclonal antibody

Pre-made anti-PIGH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PIGH/PIGH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1391-Ab-1/ GM-Tg-hg-IP1391-Ab-2Anti-Human PIGH monoclonal antibodyHuman
GM-Tg-rg-IP1391-Ab-1/ GM-Tg-rg-IP1391-Ab-2Anti-Rat PIGH monoclonal antibodyRat
GM-Tg-mg-IP1391-Ab-1/ GM-Tg-mg-IP1391-Ab-2Anti-Mouse PIGH monoclonal antibodyMouse
GM-Tg-cynog-IP1391-Ab-1/ GM-Tg-cynog-IP1391-Ab-2Anti-Cynomolgus/ Rhesus macaque PIGH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1391-Ab-1/ GM-Tg-felg-IP1391-Ab-2Anti-Feline PIGH monoclonal antibodyFeline
GM-Tg-cang-IP1391-Ab-1/ GM-Tg-cang-IP1391-Ab-2Anti-Canine PIGH monoclonal antibodyCanine
GM-Tg-bovg-IP1391-Ab-1/ GM-Tg-bovg-IP1391-Ab-2Anti-Bovine PIGH monoclonal antibodyBovine
GM-Tg-equg-IP1391-Ab-1/ GM-Tg-equg-IP1391-Ab-2Anti-Equine PIGH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1391-Ab-1/ GM-Tg-hg-IP1391-Ab-2; GM-Tg-rg-IP1391-Ab-1/ GM-Tg-rg-IP1391-Ab-2;
GM-Tg-mg-IP1391-Ab-1/ GM-Tg-mg-IP1391-Ab-2; GM-Tg-cynog-IP1391-Ab-1/ GM-Tg-cynog-IP1391-Ab-2;
GM-Tg-felg-IP1391-Ab-1/ GM-Tg-felg-IP1391-Ab-2; GM-Tg-cang-IP1391-Ab-1/ GM-Tg-cang-IP1391-Ab-2;
GM-Tg-bovg-IP1391-Ab-1/ GM-Tg-bovg-IP1391-Ab-2; GM-Tg-equg-IP1391-Ab-1/ GM-Tg-equg-IP1391-Ab-2
Products NameAnti-PIGH monoclonal antibody
Formatmab
Target NamePIGH
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PIGH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1391-Ag-1Recombinant multi-species PIGH/ GPI-H protein


    Target information

    Target IDGM-IP1391
    Target NamePIGH
    Gene ID5283,110417,362756,710780,611566,101092442,515306,100052868
    Gene Symbol and Synonyms2210416H01Rik,A930028P05Rik,GPI-H,PIG-H,PIGH
    Uniprot AccessionQ14442,Q32L89
    Uniprot Entry NamePIGH_HUMAN,PIGH_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100564
    Target ClassificationN/A

    The target: PIGH, gene name: PIGH, also named as GPI-H. This gene encodes an endoplasmic reticulum associated protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI anchor is a glycolipid found on many blood cells and which serves to anchor proteins to the cell surface. The protein encoded by this gene is a subunit of the GPI N-acetylglucosaminyl (GlcNAc) transferase that transfers GlcNAc to phosphatidylinositol (PI) on the cytoplasmic side of the endoplasmic reticulum. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.